Advisor Consultant Network’s Teva Pharmaceuticals TEVA Stock Holding History

Advisor Consultant Network’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$7.84M	Buy	+170,428	New	+$8.89M	1.11%	28

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Advisor Consultant Network's TEVA Position: Q3 2016 in Review

Advisor Consultant Network opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2016: 170,428 shares worth $7.84M. The stake represents 1.11% of the portfolio and ranks #28 among its holdings.

798 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Advisor Consultant Network held 170,428 shares of Teva Pharmaceuticals worth $7.84M as of Q3 2016.
Teva Pharmaceuticals was a new Advisor Consultant Network position in Q3 2016.
Teva Pharmaceuticals made up 1.11% of Advisor Consultant Network's portfolio in Q3 2016, its #28 holding.
798 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Advisor Consultant Network's 13F filing for Q3 2016, filed 14 Oct 2016.